期刊文献+

大剂量阿托伐他汀对大鼠心肌梗死后心室重构的影响 被引量:1

Influence of large dose atorvastatin on ventricular remodeling in rats after myocardial infarction
下载PDF
导出
摘要 目的:探讨大剂量阿托伐他汀治疗对大鼠心肌梗死后心室重构的影响。方法:将48只雄性SD大鼠随机均分为心肌梗死对照组(以去离子水灌胃)、常规剂量组(阿托伐他汀20mg/kg,在建立心肌梗死模型前后4周灌胃给药)和大剂量组(阿托伐他汀80mg/kg,给药方式同常规剂量组)。梗死后2d,采用苏木素伊红染色检测心肌组织病理变化,4周后采用Masson染色评价心肌纤维化,心脏彩超评价心腔大小和心脏功能,并进行各组间比较。结果:病理变化:梗死后2d,心肌梗死对照组着色深浅不均匀;肌纤维排列紊乱,有大片胶原纤维,有部分肌溶灶;常规剂量组着色深浅欠均匀,肌纤维排列不规则,胶原纤维较少,少数肌溶灶;而大剂量组着色深浅略不均匀,肌纤维排列尚规则,极少肌溶灶,且4周后仍有较多存活心肌,心肌细胞间隙见少量胶原纤维。左室结构与功能变化:与心肌梗死对照组,常规剂量组相比,大剂量组左室舒张末期容积[LVEDd,(7.68±0.54)ml比(7.06±0.68)ml比(6.37±0.40)ml]明显减小,左室射血分数[LVEF,(33.0±7.9)%比(39.3±2.8)%比(48.7%±9.1)%]明显提高(P<0.05或<0.01);而心肌梗死对照组与常规剂量组间LVEDd,LVEF均无显著差异(P分别为0.059,0.146)。结论:大剂量阿托伐他汀能显著减轻梗死后心室重构。 Objective:To explore influence of large dose atorvastatin therapy on ventricular remodeling in rats after myocardial infarction.Methods:A total of 48 male SD rats were randomly and equally divided into myocardial infarction(MI)control group(received deionized water gavage),routine dose group(received atorvastatin 20mg/kg gavage four weeks before and after MI model was established)and large dose group(received atorvastatin 80mg/kg,in the same way as routine dose group).On two days after MI,hematoxylin eosin(HE)staining was used to detect pathological changes of myocardial tissue;four weeks later,Masson staining was used to evaluate myocardial fibrosis while echocardiography was used to assess cardiac chamber size and heart function,the results were compared among three groups.Results:Pathologic change:On two days after MI,color of stained myocardial tissue was uneven,muscular fiber arranged in turbulence,there were partial dissolved muscle focus and blockbuster collagenous fiber in MI control group;color of stained myocardial tissue was lack of even,arrangement of muscular fiber was irregular,there were less dissolved muscle focus and collagenous fiber in routine dose group;color of stained myocardial tissue was slightly uneven,muscular fiber still arranged in rules and there was very few dissolved muscle focus and still more survived myocardium in infarct area,and small amount of collagen fibrosis was found in myocardial cell clearance after four weeks in large dose group.Change of left ventricular structure and function:Compared with MI control group and routine dose group,the left ventricular end-diastolic dimension[LVEDd,(7.68±0.54)ml vs.(7.06±0.68)ml vs.(6.37±0.40)ml]significantly reduced in large dose group,left ventricular ejection fraction[LVEF,(33.0±7.9)% vs.(39.3±2.8)% vs.(48.7%±9.1)%]significantly rose(P〈0.05,or0.01);but those indexes no significant difference between MI control group and routine dose group(P=0.059,0.146respectively).Conclusion:Large dose atorvastatin may significantly relieve ventricular remodeling after infarction.
作者 范林 林朝贵
出处 《心血管康复医学杂志》 CAS 2015年第4期411-415,共5页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 福建医科大学苗圃科研基金资助项目(2010MP042)~~
关键词 心肌梗死 心室重构 阿托伐他汀 Myocardial infarction Ventricular remodeling Atorvastatin
  • 相关文献

参考文献3

二级参考文献47

  • 1郑刚,张承宗.解读急性冠状动脉综合征他汀类药物治疗作用的临床证据(二)[J].中国心血管病研究,2004,2(7):491-492. 被引量:12
  • 2Maintz D, Seifarth H, Raupach R, et al. 64-slice multidetector coronary CT angiography~ in vitro evaluation of 68 diferent stents [J]. EurRadiol, 2006, 16 (4)~ 818--826.
  • 3Chang SM, Yazbek N, Lakkis, NM, et al. Use of statins pri- or to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome [J]. Catheter Cardiovasc Interv, 2004, 62 (2).- 193--197.
  • 4Briguori C, Colombo A, Airoldi F, et al. Statin administration before percutaneous coronary intervention~ impact on periproce- duralmyocardialinfarction ~J~. Eur Heart J, 2004, 25 (20): 1822--1828.
  • 5Thygesen, Alpert JS, White HD, et al. Universal definition of myocardial infarction [J]. J Am Coll Cardiol, 2007, 50 (22): 2173--2195.
  • 6Cannon CP, Braunwald E, McCabe CH, et al. Comparison of intensive and moderate lipid lowering with statins after acute cor- onary sydromes FJ]. N EnglJ Med, 2004, 350 (75): 1495 1504.
  • 7Yun KH, Oh SK, Rhee SJ, et al. 12 month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome [J2. Int J Cardiol, 2011, 146 (1): 68--72.
  • 8Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 2009, 15: RA209-RA219.
  • 9Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart dis?ease-a novel therapeutic target? FASEBJ 2002, 16: 135-146.
  • 10Navarra T, Del Turco S, Berti S, Basta G. The lectin-like oxidized low?density lipoprotein receptor-l and its soluble form: cardiovascular implica?tions. J Atheroscler Thromb 2010, 17: 317-331.

共引文献28

同被引文献16

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部